publication venue for
- Facets of language performance in early-onset and late-onset Alzheimer's disease dementia.. 21. 2025
- Arterial stiffness moderates the link between NfL and cognition: The IGNITE study.. 21. 2025
- Decreased quantitative transport mapping velocity in the middle cerebral artery-supplied temporal lobe in Alzheimer's disease.. 21. 2025
- Mitochondrial complex I deficiency induces Alzheimer's disease-like signatures that are reversible by targeted therapy.. 21. 2025
- Performance of computed tomography and magnetic resonance morphometry in evaluating brain atrophy in Down syndrome.. 21. 2025
- Directionality bias underpins divergent spatiotemporal progression of Alzheimer-related tauopathy in mouse models.. 21. 2025
- Heterogeneous tau deposition patterns in the preclinical stage link to domain-specific cognitive deficits.. 21. 2025
- Blood biomarkers differentiate AD-related versus non-AD-related cognitive deficits.. 21. 2025
- Eating and swallowing care disparities in persons with dementia: A conceptual framework.. 21. 2025
- Alzheimer's disease-associated CD83(+) microglia are linked with increased immunoglobulin G4 and human cytomegalovirus in the gut, vagal nerve, and brain. 2024
- Influence of medical conditions on the diagnostic accuracy of plasma p-tau217 and p-tau217/Aβ42.. 21. 2024
- Single-microglia transcriptomic transition network-based prediction and real-world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's disease. 2024
- APOE ε4-associated heterogeneity of neuroimaging biomarkers across the Alzheimer's disease continuum. 2024
- Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer's disease and progressive supranuclear palsy.. 20. 2024
- tPA supplementation preserves neurovascular and cognitive function in Tg2576 mice. 2024
- Longitudinal trajectories of Alzheimer's disease CSF biomarkers and blood pressure in cognitively healthy subjects.. 20. 2024
- Characterizing molecular and synaptic signatures in mouse models of late-onset Alzheimer's disease independent of amyloid and tau pathology. 2024
- Metabolomics profiling reveals distinct, sex-specific signatures in serum and brain metabolomes in mouse models of Alzheimer's disease.. 20. 2024
- Parenchymal CSF fraction is a measure of brain glymphatic clearance and positively associated with amyloid beta deposition on PET.. 20. 2024
- An outcome-wide analysis of the effects of diagnostic labeling of Alzheimer's disease and related dementias on social relationships.. 20. 2023
- Advancing specificity in delirium: The delirium subtyping initiative.. 20. 2023
- Catalyzing dementia care through the learning health system and consumer health information technology. 2023
- Association of liver fibrosis with cognitive test performance and brain imaging parameters in the UK Biobank study. 2022
- CRISPR/Cas9 screen in human iPSC-derived cortical neurons identifies NEK6 as a novel disease modifier of C9orf72 poly(PR) toxicity.. 19. 2022
- The landscape of metabolic brain alterations in Alzheimer's disease.. 19. 2022
- Predictive metabolic networks reveal sex- and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer's disease.. 19. 2022
- Consideration of sex and gender in Alzheimer's disease and related disorders from a global perspective.. 18. 2022
- Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease.. 18. 2021
- Patterns of tau pathology identified with 18 F-MK-6240 PET imaging.. 18. 2021
- Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients.. 17. 2020
- Individualized clinical management of patients at risk for Alzheimer's dementia.. 15. 2019
- Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.. 15. 2018
- Regional vulnerability in Alzheimer's disease: The role of cell-autonomous and transneuronal processes.. 14. 2018
- Tau and amyloid β proteins distinctively associate to functional network changes in the aging brain.. 13. 2017
- Metabolic network failures in Alzheimer's disease: A biochemical road map.. 13. 2017
- Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.. 13. 2016
- A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease.. 11. 2014
- APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role?. 10. 2014
- Widespread white matter degeneration preceding the onset of dementia.. 11. 2014
- Serial position effects are sensitive predictors of conversion from MCI to Alzheimer's disease dementia.. 10. 2014
- Comparing new templates and atlas-based segmentations in the volumetric analysis of brain magnetic resonance images for diagnosing Alzheimer's disease.. 8. 2012
- Predictors for cognitive decline in patients with confluent white matter hyperintensities.. 8. 2012
- Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment.. 7. 2011
- Magnetic resonance imaging-measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer's disease patients.. 7. 2011
- Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease.. 7. 2011
- Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia.. 7. 2011
- Transcranial doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's disease.. 7. 2011
- Vascular dysfunction-The disregarded partner of Alzheimer's disease.. 15. 2019
- The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach.. 14. 2018
- Potential roles of digital technologies in clinical trials.. 13. 2017
- Epigenetics of dementia remains unraveled in Latin American and Caribbean populations: A call for collaborative efforts. 2024
- Recommendations for a new perioperative cognitive impairment nomenclature. 2019
- The Vascular Impairment of Cognition Classification Consensus Study. 2016
- Preventing dementia by preventing stroke: The Berlin Manifesto. 2019
- Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation. 2016
- Vascular contributions to cognitive impairment and dementia including Alzheimer's disease. 2014
- The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier). 2012
- Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: A systematic review and meta-analysis. 2024
- Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity Conference. 2024
- Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference. 2024
- Novel avenues of tau research. 2024
- Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias. 2022
- Military-related risk factors for dementia. 2018